Skip to main content

Table 1 Mean dietary intake of macronutrients/nutrients, GI and GL estimated by 3-day WFR and 24-h urinary C-peptide excretion during the 6-month diet intervention

From: Assessment of dietary exposure related to dietary GI and fibre intake in a nutritional metabolomic study of human urine

 

LGI/LP

(n = 20)

HGI/LP

(n = 15)

LGI/HP

(n = 21)

HGI/HP

(n = 21)

P

Main effect of time

P

Main effect of treatment

P

Time × treatment

Men/women

8/12

4/11

11/10

10/11

   

EI

    

<0.0001

NS

NS

 Baseline (MJ)

8.95 ± 0.65a

11.96 ± 0.76

10.22 ± 0.62

10.16 ± 0.63

   

 Month 1 (MJ)

5.04 ± 0.65

6.17 ± 0.73

6.39 ± 0.62

7.36 ± 0.64

   

 Month 6 (MJ)

5.33 ± 0.63

5.36 ± 0.73

5.88 ± 0.66

5.37 ± 0.64

   

CHO

    

–

–

<0.0001

 Aim

57–62

57–62

45–50

45–50

   

 Baseline (% E)

46.2 ± 1.5

47.1 ± 1.9

44.7 ± 1.5

47.9 ± 1.5

   

 Month 1 (% E)

55.2 ± 1.7b

57.3 ± 1.7c,d

43.5 ± 1.5

48.7 ± 1.5

   

 Month 6 (% E)

52.3 ± 1.7

57.1 ± 1.8e,f

46.7 ± 1.7

48.4 ± 1.5

   

Fibre

    

<0.0001

NS

NS

 Baseline (g/day)

19.9 ± 2.5

20.7 ± 2.7

18.2 ± 2.3

19.5 ± 2.4

   

 Month 1 (g/day)

31.9 ± 2.6

26.1 ± 2.7

24.6 ± 2.4

21.7 ± 2.4

   

 Month 6 (g/day)

32.7 ± 2.7

25.8 ± 2.9

25.2 ± 2.7

22.0 ± 2.6

   

Sugar

    

0.056

NS

NS

 Baseline (g/day)

74.9 ± 6.2

62.2 ± 7.7

63.4 ± 5.9

66.3 ± 6.0

   

 Month 1 (g/day)

67.7 ± 7.0

92.1 ± 6.7

85.7 ± 6.1

80.8 ± 6.0

   

 Month 6 (g/day)

70.8 ± 7.2

84.5 ± 7.1

68.6 ± 6.9

80.8 ± 6.3

   

Starch

    

0.014

NS

NS

 Baseline (g/day)

104 ± 7.7

114 ± 9.7

108 ± 7.4

116 ± 7.6

   

 Month 1 (g/day)

140 ± 8.8

126 ± 8.3

124 ± 7.6

128 ± 7.5

   

 Month 6 (g/day)

136 ± 9.1

125 ± 9.1

136 ± 8.7

130 ± 8.0

   

Protein

    

–

–

<0.0001

 Aim

10–15

10–15

23–28

23–28

   

 Baseline (% E)

19.1 ± 0.9

17.9 ± 1.1

17.4 ± 0.9

16.8 ± 0.9

   

 Month 1 (% E)

15.0 ± 1.0

17.4 ± 0.9

23.8 ± 0.9

21.6 ± 0.9

   

 Month 6 (% E)

18.0 ± 1.0

17.7 ± 1.1

23.5 ± 1.0

25.1 ± 0.9

   

Fat

    

<0.0001

NS

NS

 Aim

25–30

25–30

25–30

25–30

   

 Baseline (% E)

31.9 ± 1.5

31.9 ± 1.9

33.3 ± 1.5

32.5 ± 1.5

   

 Month 1 (% E)

29.1 ± 1.7

26.2 ± 1.7

30.3 ± 1.5

28.4 ± 1.5

   

 Month 6 (% E)

27.6 ± 1.8

24.7 ± 1.8

26.3 ± 1.7

26.3 ± 1.6

   

GI

    

–

–

<0.0001

 Baseline (Units)

66.0 ± 1.2

64.2 ± 1.3

65.0 ± 1.1

63.3 ± 1.1

   

 Month 1 (Units)

59.0 ± 1.3g

63.2 ± 1.3

60.0 ± 1.1h

66.1 ± 1.2

   

 Month 6 (Units)

59.0 ± 1.4

64.8 ± 1.4

58.6 ± 1.4

63.4 ± 1.3

   

GL

    

<0.0001

NS

NS

 Baseline (g/day)

172 ± 12.5

230.5 ± 14.4

175.3 ± 11.6

193.1 ± 11.8

   

 Month 1 (g/day)

131.1 ± 13.1

129.1 ± 14.1

97.1 ± 11.8

129.8 ± 12.2

   

 Month 6 (g/day)

158.6 ± 13.9

156.9 ± 15.0

124.3 ± 13.3

127.3 ± 12.8

   

U-C-peptidei (nmol/24 h)

    

<0.0001

NS

NS

 Baseline

33.9 ± 3.3

33.5 ± 3.7

35.1 ± 3.1

27.2 ± 2.9

   

 Month 1

16.4 ± 3.7

19.7 ± 3.7

17.6 ± 3.2

17.1 ± 3.2

   

 Month 3

17.9 ± 3.4

21.1 ± 3.5

15.0 ± 3.4

17.7 ± 3.3

   

 Month 6

24.6 ± 3.9

20.7 ± 4.1

26.0 ± 3.8

18.0 ± 3.4

   

BMI

    

<0.0001

NS

NS

 Baseline (kg/m2)

35.6 ± 1.7

32.5 ± 2.1

34.8 ± 1.7

33.0 ± 1.8

   

 Month 1 (kg/m2)

29.4 ± 2.0

25.4 ± 1.9

29.3 ± 1.8

26.7 ± 1.7

   

 Month 3 (kg/m2)

31.3 ± 2.0

26.6 ± 2.0

29.7 ± 1.8

26.3 ± 1.7

   

 Month 6 (kg/m2)

32.0 ± 2.0

28.8 ± 2.0

31.8 ± 1.9

29.4 ± 1.8

   
  1. LGI low glycaemic index, HGI high glycaemic index, LP low protein, HP high protein, CHO carbohydrate, % E % of energy
  2. ax ± SE (all such values)
  3. bTime × treatment: interaction P < 0.0001 as compared to LGI/HP, month 1
  4. cTime × treatment: P < 0.0001 as compared to LGI/HP, month 1
  5. dTime × treatment: P = 0.005 as compared to HGI/HP, month 1
  6. eTime × treatment: P = 0.002 as compared to LGI/HP, month 6
  7. fTime × treatment: P = 0.015 as compared to HGI/HP, month 6
  8. gTime × treatment: P = 0.005 as compared to HGI/HP, month 1
  9. hTime × treatment: P = 0.017 as compared to HGI/HP, month 1
  10. iSignificant covariate: gender